Clinical End Points in Coronary Stent TrialsDonald E. Cutlip, Patrick W. Serruys, Stephan Windecker et al.|Circulation|2007Cited by 5.4k
A Controlled Trial of Renal Denervation for Resistant HypertensionDeepak L. Bhatt, George L. Bakris, David E. Kandzari et al.|New England Journal of Medicine|2014Cited by 2.2k
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery DiseaseBjarne Linde Nørgaard, Stephan Achenbach, Jonathon Leipsic et al.|Journal of the American College of Cardiology|2014Cited by 1.5k
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A. Hicks, Robert J. Temple, Cathy Sila et al.|Circulation|2018Cited by 712
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E. Kandzari, George L. Bakris, Deepak L. Bhatt et al.|European Heart Journal|2014Cited by 540